| Author(s) | |
|---|---|
| Publication Year | |
| Publisher |
Pharmacare:
Equity, Efficiency, and Effectiveness — We’ve Waited Long Enough.
From: Medicare
$0.80
Analyzes the debate about pharmacare by noting the similarity between how we fund perscription drugs and the way America funds their entire health care system and notes our rejection of this system. Pharmacare makes sense on all three grounds: equity, economic efficiency, and effective prescribing. It’s time to stop waiting for it.
Contributors
Joel Lexchin
Joel Lexchin, for the past nineteen years, has been an emergency physician at the University Health Network. He is currently a professor in the School of Health Policy and Management at York University and an associate professor in the Department of Family and Community Medicine at the University of Toronto. He has been a consultant on pharmaceutical issues for the province of Ontario, various agencies of the federal government, the World Health Organization, the government of New Zealand and the Australian National Prescribing Service. He is the author or co-author of over seventy peer-reviewed articles on topics such as physician prescribing behaviour, pharmaceutical patent issues, drug approval process, and prescription drug promotion
